MedTrace Logo

A Peri-intubation Oral Intervention to Reduce Oral Flora and VAP

NCT00248300 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2015-11-11

No results posted yet for this study

Summary

The purpose of this study is determine if a single, early dose of chlorhexidine applied within 12 hours after endotracheal tube insertion will reduce the bacteria in the oral cavity and the incidence of pneumonia in trauma victims.

Conditions

Interventions

OTHER

Chlorhexidine

Chlorhexidine, 5 ml swab to the oral cavity within 12 hours of endotracheal tube intubation

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • Uniformed Services University of the Health Sciences

    collaborator FED

  • TriService Nursing Research Program

    collaborator OTHER

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Mary Jo E Grap, PhD · Virginia Commonwealth University School of Nursing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00248300 on ClinicalTrials.gov